UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis

Oncogene, 2012-02, Vol.31 (6), p.706-715

2012

Volltextzugriff (PDF)

Copine-III interacts with ErbB2 and promotes tumor cell migration

Oncogene, 2010-03, Vol.29 (11), p.1598-1610

2010

Volltextzugriff (PDF)

Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells

Cancer research (Chicago, Ill.), 2001, Vol.61 (1), p.383-391

2001

Volltextzugriff (PDF)

The role of overexpressed HER2 in transformation

Annals of oncology, 2001, Vol.12, p.9-13

2001

Volltextzugriff (PDF)

ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer

The EMBO journal, 1996-01, Vol.15 (2), p.254-264

1996

Volltextzugriff (PDF)

The ErbB receptor tyrosine family as signal integrators

Endocrine-related cancer, 2001-09, Vol.8 (3), p.151-159

2001

Volltextzugriff (PDF)

Mammary gland growth factors: roles in normal development and in cancer

Cold Spring Harbor perspectives in biology, 2010-08, Vol.2 (8), p.a003186-a003186

2010

Volltextzugriff (PDF)

Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis

Oncogene, 2000-07, Vol.19 (31), p.3460-3469

2000

Volltextzugriff (PDF)

Modulation of p27/Cdk2 complex formation through 4d5-mediated inhibition of HER2 receptor signaling

Annals of oncology, 2001, Vol.12, p.21-22

2001

Volltextzugriff (PDF)

The ErbB2/ErbB3 Heterodimer Functions as an Oncogenic Unit: ErbB2 Requires ErbB3 to Drive Breast Tumor Cell Proliferation

Proceedings of the National Academy of Sciences - PNAS, 2003-07, Vol.100 (15), p.8933-8938

2003

Volltextzugriff (PDF)

Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells

Oncogene, 2000-03, Vol.19 (13), p.1647-1656

2000

Volltextzugriff (PDF)

The ErbB signaling network: receptor heterodimerization in development and cancer

The EMBO journal, 2000-07, Vol.19 (13), p.3159-3167

2000

Volltextzugriff (PDF)

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

Molecular and Cellular Biology, 1995-03, Vol.15 (3), p.1182-1191

1995

Volltextzugriff (PDF)

Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates

British journal of cancer, 2001-11, Vol.85 (11), p.1787-1793

2001

Volltextzugriff (PDF)

Tyrosine kinase signalling in breast cancer

Breast cancer research : BCR, 2000-01, Vol.2 (3), p.154-157, Article 154

Hynes, N E

2000

Volltextzugriff (PDF)

Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins

Oncogene, 2004-04, Vol.23 (20), p.3501-3508

2004

Volltextzugriff (PDF)

The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides

Cancer research (Chicago, Ill.), 2002-06, Vol.62 (11), p.3151-3158

2002

Volltextzugriff (PDF)

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2

Molecular and Cellular Biology, 1995-12, Vol.15 (12), p.6496-6505

1995

Volltextzugriff (PDF)

The ErbB-2/HER2 Oncoprotein of Human Carcinomas May Function Solely as a Shared Coreceptor for Multiple Stroma-Derived Growth Factors

Proceedings of the National Academy of Sciences - PNAS, 1999-04, Vol.96 (9), p.4995-5000

1999

Volltextzugriff (PDF)

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

The EMBO journal, 1997-04, Vol.16 (7), p.1647-1655

1997

Volltextzugriff (PDF)

p53-Dependent and p53-Independent Activation of Apoptosis in Mammary Epithelial Cells Reveals a Survival Function of EGF and Insulin

The Journal of cell biology, 1995-03, Vol.128 (6), p.1185-1196

1995

Volltextzugriff (PDF)

A new therapeutic antibody masks ErbB2 to its partners

Cancer Cell, 2004-04, Vol.5 (4), p.299-301

2004

Volltextzugriff (PDF)

Intracellular expression of single chain antibodies reverts ErbB-2 transformation

The Journal of biological chemistry, 1994-09, Vol.269 (39), p.23931-23936

1994

Volltextzugriff (PDF)

Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells

Cancer research (Chicago, Ill.), 1997-09, Vol.57 (17), p.3804-3811

1997

Volltextzugriff (PDF)

NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells : role of PI3 kinase and p38 MAP kinase pathways

Oncogene, 1999-06, Vol.18 (23), p.3440-3451

1999

Volltextzugriff (PDF)

1 – 25 von 457

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(399)
Mit Volltextzugriff
(380)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(305)
Life Sciences & Biomedicine
(258)
Humans
(167)
Animals
(142)
Female
(122)
Biological And Medical Sciences
(105)
Mice
(96)
Biochemistry & Molecular Biology
(76)
Cell Biology
(65)
Oncology
(61)
Male
(59)
Fundamental And Applied Biological Sciences. Psychology
(55)
Medical Sciences
(55)
Middle Aged
(38)
Physical Sciences
(36)
Aged
(35)
Molecular And Cellular Biology
(34)
Phosphorylation
(34)
Adult
(33)
Cell Line
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis

Copine-III interacts with ErbB2 and promotes tumor cell migration

Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells

The role of overexpressed HER2 in transformation

ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer

The ErbB receptor tyrosine family as signal integrators

Mammary gland growth factors: roles in normal development and in cancer

Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis

Modulation of p27/Cdk2 complex formation through 4d5-mediated inhibition of HER2 receptor signaling

The ErbB2/ErbB3 Heterodimer Functions as an Oncogenic Unit: ErbB2 Requires ErbB3 to Drive Breast Tumor Cell Proliferation

Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells

The ErbB signaling network: receptor heterodimerization in development and cancer

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates

Tyrosine kinase signalling in breast cancer

Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins

The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2

The ErbB-2/HER2 Oncoprotein of Human Carcinomas May Function Solely as a Shared Coreceptor for Multiple Stroma-Derived Growth Factors

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

p53-Dependent and p53-Independent Activation of Apoptosis in Mammary Epithelial Cells Reveals a Survival Function of EGF and Insulin

A new therapeutic antibody masks ErbB2 to its partners

Intracellular expression of single chain antibodies reverts ErbB-2 transformation

Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells

NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells : role of PI3 kinase and p38 MAP kinase pathways

Suchergebnisse filtern